Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Olaku 0.1% Eye Drop

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Olopatadine (0.1% w/v)

Overview Olaku 0.1% Eye Drop

Allergic conjunctivitis, marked by eye infection, itching, redness, and swelling, responds to Olaku 0.1% eye drops, an antihistamine. This medication effectively targets symptoms triggered by pollen, dust, pet dander, and other allergens. Adhere strictly to your physician's instructions for administering Olaku 0.1% eye drops, ensuring consistent application at prescribed intervals. Complete the entire treatment regimen, regardless of symptom improvement. While temporary burning, stinging, or irritation may occur, these side effects are typically short-lived.

Uses of Olaku 0.1% Eye Drop

Managing Allergic Reactions

Major Benefits of Olaku 0.1% Eye Drop:

Apply this medication externally only. Administer as directed by your physician, following the prescribed dosage and treatment schedule. Consult the product label for application instructions prior to use. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.

Common Side effects of Olaku 0.1% Eye Drop:

  • Eye pain
  • Eye irritation
  • Abnormal eye sensation
  • Eye discomfort
  • Sleepiness
  • Weakness
  • Dryness in mouth

How to use Olaku 0.1% Eye Drop:

Apply this medication externally only. Administer as directed by your physician, adhering to the prescribed dosage and treatment schedule. Consult the product label for application instructions prior to use. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.

How Olaku 0.1% Eye Drop works:

Aller-Ease Eye Drops (0.1% Olaku) provide antihistamine relief. This medication counteracts histamine, a substance causing eye redness, itching, and watering.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Olaku 0.1% Eye Drops during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Olaku 0.1% Eye Drops while breastfeeding is likely inadvisable. Available data from humans indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Using Olaku 0.1% Eye Drops may temporarily blur your vision. Refrain from driving until your eyesight returns to normal.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Olaku 0.1% Eye Drop :

Should you forget a dose of Olaku 0.1% Eye Drops, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Olaku 0.1% Eye Drop

LabelValue
Type of Compound A dibenzoxepine-based compound
Addictive None.
Type of Medication Ophthalmic medication

FAQs on Olaku 0.1% Eye Drop

Olaku 0.1% Eye Drops do not contain steroids. This medication addresses allergic conditions, primarily allergic conjunctivitis (pink eye). Always seek medical advice before using this product.
Using Olaku 0.1% Eye Drops as directed by your physician ensures optimal effectiveness. Continued use, even with symptom improvement, is crucial. Premature discontinuation of Olaku 0.1% Eye Drops may lead to symptom recurrence or exacerbation.
Olaku 0.1% Eye Drops typically do not irritate the eyes; instead, they often alleviate inflammation and irritation. Nevertheless, some individuals may encounter eye irritation, unusual sensations, or general discomfort.
Olaku 0.1% ophthalmic solution may be administered to children older than 3 years at the adult dosage. The safety profile of Olaku 0.1% eye drops in children under 3 years remains undetermined; consequently, its use in this younger age group is contraindicated.
Olaku 0.1% Eye Drops typically do not induce drowsiness. Nevertheless, somnolence may occur in certain instances. Concurrent oral use of other antihistamines alongside this eye drop may increase the likelihood of sleepiness. Refrain from operating vehicles or heavy machinery if drowsiness is experienced. Consult your physician if any discomfort arises.
Administer one drop of Olaku 0.1% Eye Drops into the affected eye(s) twice daily. The treatment period for Olaku 0.1% Eye Drops varies depending on the diagnosis, its intensity, and patient response. Treatment may extend up to four months if deemed appropriate, though the precise duration should be determined by your physician.
Using Olaku 0.1% Eye Drops as directed by your physician ensures optimal effectiveness. Continue treatment for the prescribed duration, regardless of symptom improvement. Premature discontinuation of Olaku 0.1% Eye Drops may lead to symptom recurrence or exacerbation.
Olaku 0.1% Eye Drops generally do not irritate the eyes; instead, they typically alleviate inflammation and irritation. Nevertheless, some users may report eye irritation, unusual sensations, or general eye discomfort.
Olaku 0.1% ophthalmic solution may be administered to children older than 3 years at the adult dosage. The safety and efficacy of Olaku 0.1% eye drops in children under 3 years have not been determined. Consequently, its use in this younger age group is not recommended.
Olaku 0.1% Eye Drops typically do not induce drowsiness. Nevertheless, somnolence may occur in certain instances. Concurrent oral use of other antihistamines can increase the likelihood of sleepiness. Refrain from operating vehicles or heavy machinery if drowsiness develops. Consult your physician if you experience any discomfort.
Administer one drop of Olaku 0.1% Eye Drops into the affected eye(s) twice daily. Treatment length with Olaku 0.1% Eye Drops varies depending on the condition, its severity, and individual response. Treatment may extend up to four months if deemed appropriate by your physician, though the precise duration will be determined by your doctor.
Allergic rhinitis, an allergic nasal inflammation, responds to treatment with Olaku 0.1% Eye Drops. This medication manages symptoms such as nasal discharge and sneezing. It's also indicated for certain skin conditions involving hives and itching.
Administer this medication solely as directed by your physician. The typical prescription involves one tablet twice daily, once in the morning and again following the evening meal. Your doctor will determine the precise dosage and treatment length.
Olaku 0.1% eye drops are suitable for managing persistent itching, a condition known as chronic urticaria. However, a diagnosis of the itchy condition is necessary before commencing treatment. Your physician will determine the correct dosage and treatment length.
Olaku 0.1% eye drops may provide relief from pollen-induced hay fever (pollinosis). Consult your physician before using this medication for hay fever. For pollinosis, treatment typically continues throughout the pollen season to minimize symptom recurrence.
Olaku 0.1% Eye Drop
98
MRP 120
18% off